News

Understanding the complex hormonal science behind weight loss injections - and why they must remain strictly ...
Of the total ER visits, nearly 70% involved GI issues, 15% of which led to hospitalization, according to a new study.
The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new study published Wednesday.
Semaglutide - the active ingredient in medications like Ozempic and WeGovy - is only FDA approved for Type-2 diabetes, but ...
Ozempic may improve fertility if you have PCOS. In a 2023 study, 27 women with obesity and PCOS took a weekly 0.5-milligram ...
Keeping up with the GLP-1 area is a full-time job by itself. First off, you have the recent development that these drugs are ...
Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...
Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...
The cutting-edge weight-loss drug Ozempic/Wegovy can stop and even reverse fatty liver disease, a new clinical trial has ...
Once-weekly semaglutide 2.4 mg significantly reduced steatohepatitis and liver fibrosis symptoms among adults with metabolic ...
A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition ...